OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD155 and its receptors in cancer immune escape and immunotherapy
Ruijia Zhou, Shiyin Chen, Qiwen Wu, et al.
Cancer Letters (2023) Vol. 573, pp. 216381-216381
Closed Access | Times Cited: 15

Showing 15 citing articles:

Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications
Jie Wang, Yian Wang, Xianjie Jiang, et al.
Cancer Letters (2024) Vol. 588, pp. 216758-216758
Closed Access | Times Cited: 14

Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
Ting Yu, Zhaoyun Liu, Qingxu Tao, et al.
Cancer Letters (2024) Vol. 589, pp. 216824-216824
Open Access | Times Cited: 11

Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
Kai Zhang, Yang Mi, Bohao Zhang, et al.
Oncogene (2025)
Closed Access | Times Cited: 1

Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5

From Pathogenesis to Precision Medicine: Transformative Advances in Research and Treatment of Ameloblastoma
Zhao Zhang, Gan Xiong, Cheng Wang, et al.
Cancer Letters (2025), pp. 217448-217448
Closed Access

LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy
Yajuan Yan, Ting Duan, Xiaonan Xue, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1047-1063
Open Access

CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, et al.
Journal of Molecular Medicine (2025)
Closed Access

Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma
Hui Lü, Xiaoyan Zhao, Liqiong Liu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Herb pair of Huangqi‐Danggui exerts anti‐tumor immunity to breast cancer by upregulating PIK3R1
Hai‐Xin Liu, Lian Li, Lili Hou, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 3, pp. 234-258
Open Access | Times Cited: 4

Nervous system in colorectal cancer
Chunjie Xu, Chunhui Jiang, Yuan Tian, et al.
Cancer Letters (2024), pp. 217431-217431
Closed Access | Times Cited: 3

TIGIT: A potential immunotherapy target for gynecological cancers
Siyue Jiang, Wen-Hua Wang, Yongxiu Yang
Pathology - Research and Practice (2024) Vol. 255, pp. 155202-155202
Closed Access | Times Cited: 1

CD155 as an emerging target in tumor immunotherapy
Jiang‐Wan Wu, Ying Liu, Xing‐Jie Dai, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111896-111896
Closed Access

Page 1

Scroll to top